Inhibikase Therapeutics (IKT) Property, Plant & Equipment (Net) (2022 - 2025)
Inhibikase Therapeutics' Property, Plant & Equipment (Net) was $23,687 in Q2 2025, down 60.7% from $60,235 a year earlier and down 50.5% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Property, Plant & Equipment (Net) (2022 - 2025) Analysis & Trends
At the end of FY2024, Property, Plant & Equipment (Net) at Inhibikase Therapeutics came in at $47,100, down 35.8% from FY2023.
- In earlier years, Property, Plant & Equipment (Net) was $73,372 in FY2023 (-69.0%) and $236,532 in FY2022.
- The Q2 2025 figure marks the lowest quarterly Property, Plant & Equipment (Net) in data going back to Q2 2022.
- Compared with a year earlier, Property, Plant & Equipment (Net) has declined for eight straight quarters, with an average decline of 49.4% over the last eight quarters.
- The best year-over-year quarter for Property, Plant & Equipment (Net) over five years was Q2 2023 (growth of 100.8%); the worst was Q1 2024 (a decline of 71.1%).
- Per Business Quant data, IKT's Property, Plant & Equipment (Net) in the three quarters before Q2 2025 was $47,845 (Q1 2025), $47,100 (Q4 2024) and $53,667 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 23.58 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 19.03 Bn |
| 10 | Inhibikase Therapeutics | 349.14 Mn | -236.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 23,687.00 |
| Mar 31, 2025 | 47,845.00 |
| Dec 31, 2024 | 47,100.00 |
| Sep 30, 2024 | 53,667.00 |
| Jun 30, 2024 | 60,235.00 |
| Mar 31, 2024 | 66,804.00 |
| Dec 31, 2023 | 73,372.00 |
| Sep 30, 2023 | 79,940.00 |
| Jun 30, 2023 | 86,523.00 |
| Mar 31, 2023 | 231,489.00 |
| Dec 31, 2022 | 236,532.00 |
| Sep 30, 2022 | 241,574.00 |
| Jun 30, 2022 | 43,089.00 |
API Access
Inhibikase Therapeutics Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();